Invasive Field Radiotherapy Combined with Rituximab Versus Rituximab Alone for Consolidation Therapy in Stage III Follicular Lymphoma Patients Response to R-CHOP Chemotherapy: A Randomized Clinical Study
机构：[1]Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine University of Electronic Science & Technology of China, Chengdu, China四川省肿瘤医院[2]Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China[3]Sun Yat-sen University Cancer Center, Guangzhou, China[4]Sun Yat-sen University Cancer Center, Guangzhou, China[5]Senior and Phase I Clinical Trial Ward, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine University of Electronic Science & Technology of China, Chengdu, China四川省肿瘤医院[6]West China Hospital of Sichuan University, Chengdu, China四川大学华西医院[7]Department of Oncology, Union Hospital afliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China华中科技大学同济医学院附属协和医院[8]Department of Medical Oncology, Sichuan Cancer Hospital, Chengdu, China四川省肿瘤医院[9]Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China[10]He Nan Cancer Hospital, Zhengzhou, China, Zhengzhou, China河南省肿瘤医院[11]Sichuan Provincial People’s Hospital, Chengdu, China, Chengdu, China四川省人民医院[12]Sun Yat-sen University Cancer Center, Guanzhou, China
第一作者机构：[1]Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine University of Electronic Science & Technology of China, Chengdu, China
共同第一作者：
推荐引用方式(GB/T 7714)：
Lin Tongyu,Huang He,Li Xiaoqian,et al.Invasive Field Radiotherapy Combined with Rituximab Versus Rituximab Alone for Consolidation Therapy in Stage III Follicular Lymphoma Patients Response to R-CHOP Chemotherapy: A Randomized Clinical Study[J].BLOOD.2021,138:doi:10.1182/blood-2021-146338.
APA：
Lin, Tongyu,Huang, He,Li, Xiaoqian,Hong, Huangming,Zou, Liqun...&Weng, Huawei.(2021).Invasive Field Radiotherapy Combined with Rituximab Versus Rituximab Alone for Consolidation Therapy in Stage III Follicular Lymphoma Patients Response to R-CHOP Chemotherapy: A Randomized Clinical Study.BLOOD,138,
MLA：
Lin, Tongyu,et al."Invasive Field Radiotherapy Combined with Rituximab Versus Rituximab Alone for Consolidation Therapy in Stage III Follicular Lymphoma Patients Response to R-CHOP Chemotherapy: A Randomized Clinical Study".BLOOD 138.(2021)
医学